FIRST Mouthwash BLM Interactions
There are 774 drugs known to interact with FIRST Mouthwash BLM (aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical), along with 17 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 32 are major, 715 are moderate, and 27 are minor.
- View all 774 medications that may interact with FIRST Mouthwash BLM
- View FIRST Mouthwash BLM alcohol/food interactions (2)
- View FIRST Mouthwash BLM disease interactions (17)
Most frequently checked interactions
View interaction reports for FIRST Mouthwash BLM (aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical) and the medicines listed below.
- alprazolam
- aspirin
- atorvastatin
- Benadryl (diphenhydramine)
- bupropion
- cetirizine
- cyclobenzaprine
- Cymbalta (duloxetine)
- diclofenac topical
- Diflucan (fluconazole)
- famotidine
- gabapentin
- ibuprofen
- lisinopril
- lorazepam
- magnesium oxide
- multivitamin
- omeprazole
- ondansetron
- oxycodone
- pantoprazole
- Phenergan (promethazine)
- potassium chloride
- prednisone
- promethazine
- tramadol
- trazodone
- triamcinolone topical
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
FIRST Mouthwash BLM alcohol/food interactions
There are 2 alcohol/food interactions with FIRST Mouthwash BLM (aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical).
FIRST Mouthwash BLM disease interactions
There are 17 disease interactions with FIRST Mouthwash BLM (aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical) which include:
- constipation
- depression
- inflammatory bowel disease
- intestinal obstruction disorders
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- renal dysfunction
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- resp depression
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.